Komori
ReproCELL (4978) · TargetRestated

Expanding the Customer Base into the General Consumer Market through the Cosmetics Business

First written in FY2017-Q2. 2 of 4 entries say "Advanced", first in FY2017-Q3. Latest entry: FY2018.

4entries
3years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2017-Q2AdvancedFY2017-Q3 – FY2018-Q32016: 120162017: 120172018: 22018
Same theme, other companies
Fundamental Reform of the Cosmetics Business and Expansion of Brands and Sales ChannelsA theme 24 companies write about · 1 as a headwind · 31 as a tailwind

The whole theme swung hardest in 2022: 2 of 17 companies on the "Worse" side.

2 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 24 companies compared. The sentences above are computed from all 24.
Full recordFilings, disclosures and news, newest first
  1. FY2018RestatedAnnual report

    「We will continue to promote the joint development of cosmetics utilizing our stem cell culture technology and develop new products.」

    The company has reaffirmed its policy of continuing to develop new products, consistent with the direction of expanding its customer base from corporate customers to general consumers through the cosmetics business.
  2. FY2018-Q3AdvancedAnnual report

    「リプロキレート社, our equity-method affiliate engaged in the cosmetics sales business, has begun selling its first product, “Cellarge Bio Mask.”」

    In connection with the policy of expanding the customer base from its corporate focus to general consumers, sales of the first cosmetics product began.
  3. FY2017-Q3AdvancedAnnual report

    「Our group plans to enter the cosmetics market by utilizing the stem cell culture technology we have developed and expand its primarily corporate customer base to include general consumers. We are currently working toward commercialization during fiscal 2017.」

    The company reaffirmed its policy of expanding its customer base from a corporate focus to general consumers and specified fiscal 2017 as the target timing for the underlying product commercialization.
  4. FY2017-Q2First statedAnnual report

    「By entering the cosmetics market using the stem cell culture technology we have developed, we will expand our customer base, which has primarily consisted of corporate customers, to include general consumers.」

    The company first presented its objective of expanding its customer base from its traditional focus on corporate customers to general consumers, together with entry into the cosmetics market as the means of doing so.
Moved together

"New cosmetics business combining stem cell technology and cosmetics technology" moved the same way as this thread, in the same document, in 2 of its 4 moves.

2★1
  1. ★This thread
  2. 1New cosmetics business combining stem cell technology and cosmetics technology2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for ReproCELL yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Expanding the Customer Base into the General Consumer Market through the Cosmetics Business | ReproCELL Incorporated (4978) | Komori